Literature DB >> 16308711

[Diagnostics and treatment of prostate cancer after kidney transplantation].

A Wicht1, A Hamza, H Loertzer, M Dietl, H Heynemann, P Fornara.   

Abstract

The number of patients with prostate cancer and end-stage renal disease or prostate cancer following kidney transplantation has continuously increased in industrialized countries. According to the data generated by Penn et al. a higher incidence of prostate cancer following kidney transplantation can be seen but is probably due to a more intense screening of the recipients. It is rather a common opinion that no elevated risk of prostate cancer following kidney transplantation exists. In patients with strictly localized prostate cancer curative treatment should be the aim also after kidney transplantation. Kidney transplantation does not interfere with surgical access to the prostate gland (retropubic or perineal). Nonlocal tumors of the prostate should also be treated following the general recommendations regarding prostate cancer. Looking at the current literature, a reduction or change of immunosuppression seems reasonable. It is necessary to establish a nationwide (or even European) cancer register, especially for patients before and after transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16308711     DOI: 10.1007/s00120-005-0961-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  47 in total

1.  [Urologic tumors and organ transplantation. Recommendations of the Kidney Transplantation Working Group of the Ongoing Graduate and Continuing Education Committee of the German Society of Urology].

Authors:  K Dreikorn; R Heicapell; H Heynemann; K J Klebingat; C Reek; B Schönberger; H Seiter; J M Wolff
Journal:  Urologe A       Date:  2001-11       Impact factor: 0.639

2.  Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.

Authors:  Viktor Grünwald; Linda DeGraffenried; Douglas Russel; William E Friedrichs; Ratna B Ray; Manuel Hidalgo
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

3.  Radical prostatectomy for localized prostatic carcinoma in the renal transplant patient.

Authors:  T J Kinahan; M G McLoughlin; A D Manson
Journal:  J Urol       Date:  1991-07       Impact factor: 7.450

4.  Perineal approach to radical prostatectomy in kidney transplant recipients with localized prostate cancer.

Authors:  R Yiou; L Salomon; M Colombel; J J Patard; D Chopin; C C Abbou
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

5.  Tumor markers in patients with chronic renal failure.

Authors:  X Filella; A Cases; R Molina; J Jo; J L Bedini; L Revert; A M Ballesta
Journal:  Int J Biol Markers       Date:  1990 Apr-Jun       Impact factor: 2.659

6.  Serum tumour markers in renal failure.

Authors:  N Arik; B Adam; T Akpolat; K Haşil; S Tabak
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

7.  Localized prostatic cancer in patients submitted to renal transplant.

Authors:  João C Campagnari; Luiz A A Ribeiro; Marcelo Mangini; M Campagnari; Paulo R Rodrigues; Marcio D'Imperio
Journal:  Int Braz J Urol       Date:  2002 Jul-Aug       Impact factor: 1.541

8.  Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen.

Authors:  J J Morton; S F Howe; J A Lowell; R J Stratta; R J Taylor
Journal:  Br J Urol       Date:  1995-04

9.  Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients.

Authors:  I Sasagawa; T Nakada; T Hashimoto; M Ishigooka; Y Kubota; K Hirano; J Hirano; Y Suzuki
Journal:  Urol Int       Date:  1992       Impact factor: 2.089

10.  Serum tumor markers in patients on dialysis and kidney transplantation.

Authors:  W C Lye; P Tambyah; S O Leong; E J Lee
Journal:  Adv Perit Dial       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.